SEC Form 4 · accession 0001683168-17-001724
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wright Don
Director
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.20 | Jun 30, 2017 | A | 14,254 | A | — | Jun 30, 2027 | Common Stock | 14,254 | 14,254 | D |
Explanation of responses
- F1Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant. Q2 2017